Zeller’s Balancing Act
Does CTP director Mitch Zeller fall on the side of tobacco control or harm reduction?
Three More Findings from the FDA’s Tobacco Study
PATH study data on youth access, poly-use and reduced-harm products
Does CTP director Mitch Zeller fall on the side of tobacco control or harm reduction?
PATH study data on youth access, poly-use and reduced-harm products